The £118 million Mazumdar-Shaw Advanced Research Centre (ARC) will be the creative and collaborative heart of cross-disciplinary research at the University of Glasgow.
A big boost to healthcare efforts of Ayush through NARIP, CCRAS
TP-3654 is currently being evaluated in a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with intermediate or high-risk primary or secondary myelofibrosis.
The drug will be manufactured at the group’s topical facility at Ahmedabad
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
Innate to receive $5M milestone payment from AstraZeneca
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds
Subscribe To Our Newsletter & Stay Updated
